BELITE BIO, INC BLTE

Belite Bio (BLTE) Stock Looks Fully Valued After A 431% Run

Yahoo Finance · 2026-08-14

Belite Bio Announces Tinlarebant Data Presentations at SOG and APVRS Congresses

Quiver Quantitative · 2026-08-21

How Belite Bio Inc (BLTE) Affects Rotational Strategy Timing

Stock Traders Daily · 2026-08-09

Belite Bio lead asset granted FDA priority review (BLTE:NASDAQ)

Seeking Alpha · 2026-08-12

BLTE Stock Rises as FDA Grants Priority Review to Tinlarebant NDA

TradingView · 2026-08-12

Belite Bio (BLTE) Could Be 21% Below Fair Value As FDA Priority Review Lands

Sahm · 2026-08-14

Belite Bio sets four talks at two medical meetings, including Phase 3 data

Stock Titan · 2026-08-21

Belite Bio Inc (BLTE) Stock News Today

TradingKey · 2026-08-17

When Can We Expect A Profit From Belite Bio, Inc (NASDAQ:BLTE)?

Yahoo Finance · 2026-04-13

Belite Bio Reports FDA Acceptance of NDA for Tinlarebant with Priority Review for Stargardt Disease Type 1

Quiver Quantitative · 2026-08-13

Belite Bio: The Oral Route Is The Real Competitive Moat (NASDAQ:BLTE)

Seeking Alpha · 2026-07-29

Belite Bio shares rise after first-quarter earnings outperform expectations (BLTE)

Yahoo Finance · 2026-05-20

Belite Bio (NASDAQ: BLTE) wins FDA priority review for tinlarebant in Stargardt disease

Stock Titan · 2026-08-11

We're Not Worried About Belite Bio's (NASDAQ:BLTE) Cash Burn

Yahoo Finance · 2026-06-12

BLTE (NASDAQ: BLTE) files Form 144 for 93,800 ADS sale

Stock Titan · 2026-08-12

Show 10 more ↓

Upstream Bio, Inc. (UPB) UPB Trevi Therapeutics, Inc. (TRVI) TRVI Neuphoria Therapeutics Inc. (NEUP) NEUP Nuvation Bio Inc. (NUVB) NUVB Travere Therapeutics, Inc. (TVTX) TVTX